Azala

NASH and Systemic Complications

Nonalcoholic fatty liver disease (NAFLD) is known as the hepatic manifestation of the metabolic syndrome, and while most patients develop simple steatosis, up to one-third can develop nonalcoholic steatohepatitis (NASH). NASH is a chronic inflammatory condition of the liver that can further progress...

Deskribapen osoa

Gorde:
Formatua: Online
Hizkuntza:ingelesa
Argitaratua: MDPI - Multidisciplinary Digital Publishing Institute 2022
Gaiak:
NAFLD
mouse models
multifactorial disease
translational value
non-alcoholic fatty liver disease
steatohepatitis
NASH
cognitive impairment
memory dysfunction
Alzheimer’s disease
neurodegeneration
liver stiffness
liver steatosis
controlled attenuation parameter
transient elastography
MRI PDFF
MR spectroscopy
non-alcoholic steatohepatitis (NASH)
tunneling nanotubes (TNTs)
primary hepatocytes
organelle transfer
mesenchymal stromal cells
aminopyrine
microsomal
liver function
breath test
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
extracellular vesicles
magnesium (Mg2+)
obesity
insulin resistance (IR)
type 2 diabetes mellitus (T2DM)
hypertension
cardiovascular diseases (CVD)
non-alcoholic steatohepatitis
intestinal permeability
microbiota
probiotics
physical exercise
fecal microbiota transplantation
hepatocellular carcinoma
pathogenesis
extra-hepatic outcome
organ-on-a-chip
artificial intelligence
liver disease
GLP-1 agonist
SGLT-2 inhibitor
type 2 diabetes
innate immune system
adaptive immune system
metabolic syndrome
fatty liver
leptin
n/a
thema EDItEUR::G Reference, Information and Interdisciplinary subjects::GP Research and information: general
Sarrera elektronikoa:ONIX_20220224_9783036529790_116
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak: NASH and Systemic Complications

Antzeko izenburuak